News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PsychoGenics Inc. Obtains An Exclusive License To The Rtg4510 Tauopathy Mouse Model


1/31/2014 9:25:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics Inc. announced today that it has obtained licenses to the rTg4510 tauopathy mouse from Mayo Clinic and TET Systems GmbH & Co. KG (TET Systems). The rTg4510 mouse expresses the P301L mutation in the tau gene associated with frontotemporal dementia and Parkinsonism linked to chromosome 17. Transgene expression in this model is induced via the tetracycline-operon responsive element (licensed from TET Systems) and is reversibly suppressed after treatment with doxycycline.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES